Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial - Maher, Toby M.; Corte, Tamera J.; Fischer, Aryeh; Kreuter, Michael; Lederer, David J.; Molina-Molina, Maria; Axmann, Judit; Kirchgaessler, Klaus-Uwe; Cottin, Vincent (BMJ Open Respiratory Research, 2018)
Gesehen am 12.09.2019